Table 5.
Characteristics of Eyes with and without RNV Progression
| Parameters | RNV Progression (+) (n = 10) |
RNV Progression (−) (n = 10) |
P Value |
|---|---|---|---|
| Age, yrs (SD) [95% CI] | 47.0 (10.3) [39.7–54.3] | 59.9 (10.9) [52.1–67.7] | 0.014† |
| Sex, n (male/female) | 6/4 | 5/5 | 1.00∗ |
| Most recent HbA1c, % (SD) [95% CI] | 8.6 (3.0) [6.5–10.8] | 7.3 (1.3) [6.4–8.2] | 0.21† |
| Duration of DM, yrs (SD) [95% CI] | 22.2 (7.3) [17.0–27.4] | 21.2 (16.4) [9.5–32.94] | 0.86† |
| Type 1 DM, n (%) | 6 (60) | 4 (40) | 0.66∗ |
| Follow-up duration, mos (SD) [95% CI] | 13.1 (8.2) [7.3–18.9] | 17.9 (13.0) [8.6–27.2] | 0.33† |
| OCTA scans, n (SD) [95% CI] | 3.3 (1.2) [2.5–4.1] | 3.4 (1.3) [2.5–4.3] | 0.86† |
| DR stage | |||
| Moderate NPDR, eyes (%) | 1 (10.0) | 0 (0.0) | 1.00∗ |
| Severe NPDR, eyes (%) | 3 (30.0) | 3 (30.0) | |
| PDR, eyes (%) | 6 (60.0) | 7 (70.0) | |
| Treatment naive, eyes (%) | 8 (80) | 3(30) | 0.070∗ |
| Treatments during the follow-up, eyes (%) | 5 (50) | 5 (50) | 1.00∗ |
CI = confidence interval; DM = diabetes mellitus; DR = diabetic retinopathy; HbA1c = hemoglobin A1c; NPDR = nonproliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy; SD = standard deviation.
∗
Fisher exact test.
†
Unpaired t test.